<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37125694</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE).</ArticleTitle><Pagination><StartPage>799</StartPage><EndPage>803</EndPage><MedlinePgn>799-803</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231173530</ELocationID><Abstract><AbstractText Label="BACKGROUND/PURPOSE" NlmCategory="UNASSIGNED">Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease, with a potential for significant disease damage, morbidity, and mortality. In comparison to the adult population, childhood-onset SLE (cSLE) tends to be more aggressive given the higher preponderance of renal and neuropsychiatric disease and increased disease activity. There is a paucity of literature examining relationship between disease activity, rheumatology follow-up visits, and health care utilization. The objective of this study is to determine whether adherence with outpatient clinic visits would affect disease activity in patients with childhood-onset systemic lupus erythematosus (cSLE).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">41 children &lt;18&#xa0;years of age at time of diagnosis with SLE who met Systemic Lupus International Collaborative Clinics (SLICC) criteria and not evaluated in clinic within the previous 120-day period were identified as eligible for inclusion. Patients were continuously searched between December 2021 and July 2022 for eligibility evaluation. Through retrospective chart review, we assessed disease activity (SLE Disease Activity Index) at the last clinic visit. The patients were stratified into two cohorts of lower and higher disease activity, with SLE disease activity index (SLEDAI) &#x2264; 3 and SLEDAI &#x2265; 4, respectively. Descriptive statistics and Willcox Rank Sum (numerical variables) and Fisher's test (categorical variables) were used to compare these two groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Clinical, epidemiological, and serological data were compared between the two groups, with observed statistically significant differences to include current use of high dose prednisone associated with higher SLEDAI scores (<i>p</i> = 0.019). In nonparametric analysis, time to follow-up (<i>p</i> &lt; 0.001), hospitalizations (<i>p</i> = 0.017), and Emergency Department visits (ED) (<i>p</i> &lt; 0.001) were found to be associated with higher SLEDAI scores.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggest that cSLE patients with higher disease activity are at risk for increased health care utilization with respect to ED visits as well as hospitalizations in the setting of follow-up nonadherence. While further studies are required to enhance our understanding of this association, this links the importance of disease-related outcome and routine outpatient visits in this particularly vulnerable patient population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Meghan Corrigan</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-5320-4045</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">12239</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">1367</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosley</LastName><ForeName>Colleen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">12239</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villacis-Nunez</LastName><ForeName>D Sofia</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">12239</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">1367</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouster-Stevens</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">12239</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">1367</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakral</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">12239</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Children's Healthcare of Atlanta, Atlanta, GA, USA.</Affiliation><Identifier Source="RINGGOLD">1367</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SLEDAI</Keyword><Keyword MajorTopicYN="N">cSLE</Keyword><Keyword MajorTopicYN="N">disease activity</Keyword><Keyword MajorTopicYN="N">healthcare utilization</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37125694</ArticleId><ArticleId IdType="doi">10.1177/09612033231173530</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>